Page last updated: 2024-10-28

ifenprodil and Learning Disabilities

ifenprodil has been researched along with Learning Disabilities in 2 studies

ifenprodil: NMDA receptor antagonist

Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huo, XL1
Min, JJ1
Pan, CY1
Zhao, CC1
Pan, LL1
Gui, FF1
Jin, L1
Wang, XT1
Shin, EJ1
Nah, SY1
Chae, JS1
Bing, G1
Shin, SW1
Yen, TP1
Baek, IH1
Kim, WK1
Maurice, T1
Nabeshima, T1
Kim, HC1

Other Studies

2 other studies available for ifenprodil and Learning Disabilities

ArticleYear
Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chronic Disease; Disease Models, Animal

2014
Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats.
    Neurochemistry international, 2007, Volume: 50, Issue:6

    Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Behavior, Animal; Dextromethorphan; Ethyl

2007